Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intracerebral Gene Therapy for Sanfilippo Type A Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
LYSOGENE
ClinicalTrials.gov Identifier:
NCT01474343
First received: November 10, 2011
Last updated: May 5, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)